Increasing dosing intervals for biologics in atopic dermatitis-why, who, when and how?

Area of Science:

• Dermatology
• Immunology
• Pharmacology

Background:

• Biologics offer effective atopic dermatitis treatment with good safety.
• Current biologic therapies have drawbacks like high cost and frequent injections.

Purpose of the Study:

• To review progress and evidence for dose elongation strategies in atopic dermatitis biologics.
• To assess the feasibility and patient population for prolonged dosing intervals.

Main Methods:

• Review of clinical trial data and real-world evidence on biologic dose elongation.
• Analysis of patient populations and emerging clinical predictors for successful prolonged dosing.

Main Results:

• A significant patient population maintains adequate atopic dermatitis control with prolonged biologic dosing intervals.
• Evidence for clinical predictors of sustained disease control is developing.

Conclusions:

• Dose elongation is a viable strategy for many atopic dermatitis patients on biologics.
• Individualized dosing through shared decision-making can optimize treatment for patients achieving good disease control.